Specialist Breast Cancer Pharmacist

We currently have an opportunity for highly motivated, enthusiastic specialist clinical pharmacist (band 8a) to join our team. The post holder will be part of the wider clinical pharmacy team providing pharmacy services to patients across all disease groups but will work predominantly within the breast cancer disease group supervising Systemic Anti-Cancer Therapies for patients with breast cancer.

The post holder(s) will be accountable for the delivery of specialist clinical pharmacy services, supporting the cancer disease group in conjunction with other specialist breast cancer pharmacists and have an active role in the outpatient clinic setting with regards to prescribing.

The Pharmacy Department actively supports a number of collaborative projects alongside several research partners and has strong links with the University of Manchester. Several members of our staff have undertaken post graduate training, research and other secondment opportunities and we are keen to support further opportunities.

If you are enthusiastic and keen to make a positive contribution to the care of cancer patients, we would like to hear from you.

To deliver and evaluate clinical pharmacy services to breast cancer patients.

To supervise and prescribe Systemic Anti-Cancer Therapies and supportive treatments for patients being treated for breast cancer.

To develop and maintain highly specialist knowledge in medicines used within the Trust especially in relation to the designated cancer disease group.

To promote the safe, efficient and cost effective use of medicine resources to the designated cancer disease group by the provision of education and training, procedures, policies and guidelines, and medicine usage information.

To contribute to the wider clinical pharmacy service for patients being treated across all disease groups.

Although the pharmacy service is based at The Christie Hospital main site, postholders may be required to work at any location across the Greater Manchester and Cheshire Cancer Network. The Trust has a flexible working policy and, subject to service commitments, it may also be possible to support an element of working from home.

The Christie is one of Europe's leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country. We provide radiotherapy through one of the largest radiotherapy departments in the world;

chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years. We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.

To provide specialist clinical pharmacy services to a designated cancer disease group in accordance with all departmental, Trust and national standards, procedures and policies. To be responsible for the direct delivery and development of an out-patient clinical practice, or within the day case setting within the Trust or at Trust peripheral locations. To work closely with and provide pharmaceutical advice to medical staff, other members of the multi-disciplinary team and patients.

To work as an independent prescriber within the designated disease group working alongside the relevant consultant team. To develop contributions to pharmacist led clinic streams e.g oral SACT delivery models, if appropriate to the designated disease group in line with service improvements. To audit and evaluate pharmacist led clinic streams / pharmacist prescribing within the designated disease group as appropriate for service evaluation and improvement.

To develop and maintain drug protocols and treatment guidelines both within the clinical pharmacy service and the designated cancer…